ARYLSULPHONYL BENZODIOXANES USED FOR MODULATING 5-HT6 RECEPTOR, 5-HT RECEPTOR OR BOTH Russian patent published in 2009 - IPC C07D319/20 C07D405/06 A61K31/357 A61P25/00 

Abstract RU 2372344 C2

FIELD: chemistry.

SUBSTANCE: present invention relates to new compounds of formula I: , where m ranges from 0 to 3, n ranges from 1 to 3, p is 0, Ar is phenyl, possibly substituted with C1-C6-alkyl, cycloalkyl, hydroxyalkyl, halogen, hydroxyl or cyano group, X is -O-,R1 and R2 each is independently hydrogen, C1-6alkyl or C1-6alkoxy-C1-6alkyl or hydroxy-C1-6alkyl, or one of R1 and R2 is hydrogen or C1-6 alkyl, and the other is C1-6alkylcarbonyl, C3-C8 cycloalkyl, aryl-C1-6alkyl or hydroxyl, or R1 and R2 together with the nitrogen atom to which they are bonded can form a three- to seven-member ring, which can possibly contain an additional N heteroatom, or R1 and R2 together with the nitrogen atom to which they are bonded can form a guanidyl group, amidinyl group, carbamyl group or urea group, each R3 is independently C1-6alkyl, R4 and R5 each is independently hydrogen or C1-6alkyl; or their pharmaceutically acceptable salts, as well as pharmaceutical compositions containing these compounds.

EFFECT: invention can selectively modulate 5-HT receptors, including 5-HT6 and 5-HT2A receptors.

17 cl, 1 tbl, 6 ex

Similar patents RU2372344C2

Title Year Author Number
BENZIMIDAZOLE AND INDOLE DERIVATIVES AS SELECTIVE 5-HT6 AND/OR 5-HT2A RECEPTOR ANTAGONISTS 2006
  • Ouehns Timoti D.
  • Setkhofer Stiven
  • Uolker Kejt Adrian Mjurrej
  • Chzhao Shu-Khaj
RU2415138C2
DERIVATIVES OF OXAZOLIDINE ANTIBIOTICS 2008
  • Gude Markus
  • Khubshverlen Kristian
  • Rjuehdi Georg
  • Sjurive Zhan-Filipp
  • Tsumbrunn-Aklen Kornelija
RU2506263C2
3-AMINO-1-ARYLPROPYLINDOLES APPLIED AS INHIBITOR MONOAMINE REUPTAKE 2005
  • Grinkhaus Robert
  • Khajme-Figejra Saul
  • Raptova Lubika
  • Shtejn Kehrin Ehnn
  • Uehjkert Robert Dzhejms
  • Rejter Debora Kehrol
RU2382031C2
ISOINDOLE COMPOUNDS AND USE THEREOF AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATION FACTORS 2005
  • Klejton Dzhoshua
  • Ma Fupeng
  • Van Vagenen Bredford
  • Ukkiramapandian Radkhakrishnan
  • Igl Ajan
  • Ehmpfild Dzhejms
  • Ajzek Metvin
  • Slassi Abdel'Malik
  • Stilmehn Gari
  • Urbanek Rebekka
  • Uolsh Salli
RU2420517C2
ANTAGONISTS OF PEPTIDE RECEPTOR FIXED WITH CALCITONIN GENE 2003
  • Chaturvedula Prasad V.
  • Chen Ling
  • Siv'Ello Rita
  • Konvehj Charlz Mark
  • Degnan Ehndrju P.
  • Dubovchik Dzhen M.
  • Khan Ksiaodzhun
  • Karadzhordzh Dzhordzh N.
  • Lao Guanglin
  • Mehkor Dzhon E.
  • Pojndekster Grehkhem
  • Vig Shikkha
RU2341526C2
HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES 2007
  • Ajer Pravin
  • Lin Klara Jeu Jen
  • Lukas Meht'Ju K.
  • Linch Stiven M.
  • Madera Ehnn Mari
  • Ozboja Kerem Ehrol
  • Shoenfeld Rajan Krejg
  • Vejkert Robert Dzhejms
RU2479575C2
TETRALINE AND INDAN DERIVATIVES AND APPLICATION THEREOF 2005
  • Grinkhaus Robert
  • Kharris Iii Ral'F N'Ju
  • Khajme-Figejra Saul
  • Kress Dzhejms M.
  • Repke Devid Brjus
  • Stabler Rassell Stefen
RU2396255C2
OXAZOLIDINONE DERIVATIVES 2009
  • Khubshverlen Kristian
  • Rjuehdi Georg
  • Sjurive Zhan-Filipp
  • Tsumbrunn-Aklen Kornelija
RU2501799C2
AZETINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS 2007
  • Ehssaui Amed
  • Boss Kristof
  • Gude Markus
  • Kobershtajn Ral'F
  • Zifferlen T'Erri
RU2447070C2
2-PHENYLAMINOPYRIMIDINE DERIVATIVES AS LEUCINE-RICH REPEAT KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON'S DISEASE 2012
  • Bejker-Glenn Charlz
  • Berdik Daniel Dzhon
  • Chembers Mark
  • Chan Brajan K.
  • Chen Khuejfen
  • Estrada Entoni
  • Ganzner-Toste Dzhanet
  • Shor Daniel
  • Svini Zakari
  • Van Shumej
  • Chzhao Gujlin
RU2661197C2

RU 2 372 344 C2

Authors

Berger Dzhejkob

Zhao Shu-Khaj

Dates

2009-11-10Published

2005-04-27Filed